Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Intelligent Bio Solutions (NASDAQ: INBS) Completes Notable Milestone in Development of its Biosensor Diagnostic Platform

Intelligent Bio Solutions, Inc. (NASDAQ: INBS) operates as a life sciences company, which is focused on the development of non-invasive, real-time diagnostic solutions. Shares of the diagnostics company skyrocketed 281% during trading on Monday, January 23, 2023. Over the past three months, Intelligent Bio Solutions has seen average daily volume of 54,420 shares. However, volume of 146.28 million shares or dollar volume of around $150.67 million, exchanged hands during the day’s trading.

Shares of Intelligent Bio Solutions surged after the company announced the completion of a key milestone in the development of its biosensor platform. The biosensor platform is the world’s first designed to support the real-time diagnostic testing of saliva based on Organic Thin Film Transistor (OTFT) technology. The OTFT is a small, printable strip that provides a quick diagnosis to patients and their medical providers.

“Milestone 7” results captured and reviewed at the University of Newcastle, Australia, which included testing time-to-result (TTR), sensitivity, and reproducibility. The resulted demonstrated a record four-times improvement in TTR, which allows the biosensor to provide test results in under one minute.

Outside of the major TTR improvements, Milestone 7 also led to the development of a new ink and device architecture that helps reduce manufacturing and printing times; ultimately improving productivity and limiting costs. In addition, Intelligent Bio Solutions made improvements in the limit of detection, which is seen as a key factor in being able to measure glucose in saliva. “Before these recent improvements, the biosensor platform was achieving 0.90 mg/dlii. Setting a more aggressive target initially improved this to 0.54 mg/dl, before later achieving a further reduction to 0.36 mg/dl on average with the lowest result being 0.22 mg/dl,” according to Intelligent Bio Solutions.

“We are thrilled to have reached another key development milestone for our biosensor platform, particularly demonstrating a substantial TTR reduction from 120 to 30 seconds, far below our original target of over 1 minute per test,” said Harry Simeonidis, Chief Executive Officer at Intelligent Bio Solutions. “Based on these successful results, the biosensor development team has now proceeded to its next testing phase, which will include testing human saliva.”

Disclosure: No position. Spotlight Growth has no relationships with any of the companies mentioned in this article and did not receive payment in any form for its creation. This is an opinion article and is not meant to be financial advise. We are not broker-dealers or investment professionals. Please conduct your own due diligence. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/

The post Intelligent Bio Solutions (NASDAQ: INBS) Completes Notable Milestone in Development of its Biosensor Diagnostic Platform appeared first on Spotlight Growth.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.